ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 681646 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 681646; 2) Community: the network communities that were significantly associated with the response to NSC 681646; 3) Molecule: the relationships between components within communities and NSC 681646; 4) MDR: the compounds that were significantly associated with the NSC 681646.

NSC Compound Enrichment Correlation
NSC 638646 4-Piperidinone, 3,5-bis[(3,4-dichlorophenyl)methylene]- 1-[3-(4-morpholinyl)-1-oxopropyl]-, monohydrochloride 0.00970780973624031 0.23233642
NSC 639174 Camptothecin Derivative 0.00970780973624031 0.91515357
NSC 639186 Raltitrexed 0.00970780973624031 0.56195914
NSC 671122 Null 0.00970780973624031 -0.020351646
NSC 674347 4-(1,1-Dimethylethyl)-1-(1-methylethyl)-{9,10-dihydro-12-met hoxy-8-hydroxymethyl-9-oxoindolizo[1,2-b]quinolin-7-yl}butanedioate 0.00970780973624031 0.76678769
NSC 678932 1H-Benzimidazole-4-carboxamide, N-[2-(dimethylamino)ethyl]-2-(4-pyridinyl)-, hydrochloride 0.00970780973624031 0.051546676
NSC 683834 Null 0.00970780973624031 0.16963983
NSC 685833 7H-Purine, 2,6-dichloro- 7-[2-deoxy-3,5-O-bis(4-methylphenyl)- .beta.-D-ribofuranosyl]- 0.00970780973624031 0.15176376
NSC 691519 Null 0.00970780973624031 0.43177428
NSC 691533 Null 0.00970780973624031 0.27833186
Total:69  Current:15    [First] [Prev] [Next] [Last]